P246: The association of serum 7α-hydroxy-4-cholesten-3-one (7C4) with Bile Acid Diarrhoea in patients with inflammatory bowel diseaseECCO '18 Vienna
2018
P247: MR enterography in Crohn’s disease: Comparison between diffusion-weighted imaging and intravenous contrast material in detection of active diseaseECCO '18 Vienna
2018
P248: IL-33/ST2 levels can predict mucosal response to anti-TNF therapy in ulcerative colitisECCO '18 Vienna
2018
P249: Endoscopic score vs. faecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healingECCO '18 Vienna
2018
P250: Serious infection in patients with Crohn’s disease newly treated with anti-integrin and anti-tumour necrosis factor agents: A real-world studyECCO '18 Vienna
2018
P251: High anti-TNF drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel diseasesECCO '18 Vienna
2018
P253: Characteristics of patients with Crohn’s disease diagnosed in the emergency department: Experience in a single tertiary hospitalECCO '18 Vienna
2018
P254: The significance of LCI Index of rectal mucosa of the patients of ulcerative colitisECCO '18 Vienna
2018
P255: Limitations of a community calprotectin service and outcomes from patients tested outside of an approved pathwayECCO '18 Vienna
2018
P256: Risk of relapse according to endoscopic score of mucosal healing (mayo score 0 vs. 1): Clinical evaluation is still necessaryECCO '18 Vienna
2018
P258: 3D printed models in fistulising perianal Crohn's as a clinical tool boost education with patients and traineesECCO '18 Vienna
2018
P259: Measures of predicting inflammatory and fibrotic strictures in Crohn’s disease patients using magnetic resonanceECCO '18 Vienna
2018
P260: Point of Care Ultrasound (POCUS) when performed by gastroenterologists with 200 supervised scans is accurate and clinically useful for patients with Crohn’s diseaseECCO '18 Vienna
2018
P261: Asking about bowel control problems in IBD: Results of face-to-face screening vs. self-reportingECCO '18 Vienna
2018
P262: New faecal calprotectin cut-off points for remission and active disease defined by UCEIS and Nancy indices in ulcerative colitis (UC)ECCO '18 Vienna
2018
P263: Evaluation of fatigue in inflammatory bowel disease: a useful tool in daily practiceECCO '18 Vienna
2018